SEC Form 4 · accession 0001209191-15-044049
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pat Controneo
Officer — VP, Finance and CFO
Period of report
May 14, 2015
Accepted (ET)
May 18, 2015 · 8:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 14, 2015 | F | 2,712 | $21.39 | D | 99,856 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 2,500 shares acquired on May 15, 2015 through the Issuer's Employee Stock Purchase Plan.